Investment Strategy Will Focus on Accelerating Treatments and a Cure PHILADELPHIA, Feb. 15, 2024 /PRNewswire/ — Beyond Celiac, the leading catalyst for a cure for celiac disease, today announces the creation of Beyond Celiac Investments (BCI), an investment program to accelerate the…
Beyond Celiac Launches First Investment Program for Celiac Disease Therapeutics
This post was originally published on this site